Feed Preview

Going Viral

Non-coding Variants in Cancer (Keystone)

Non-coding Variants in Cancer (Keystone) diagram by Ppgardne ; ilusmedical, Wikimedia
Ppgardne ; ilusmedical, Wikimedia

Mutations, single nucleotide variants and large genomic rearrangements in non-coding regions of the genome can have severe consequences such as disruption of transcription factor binding sites and functions of non-coding RNAs and can impact tumor development and progression. This feed focuses on the latest research on non-coding variants in cancer.

Top 20 most recent papers
Frontiers in Cell and Developmental Biology

A New World of Biomarkers and Therapeutics for Female Reproductive System and Breast Cancers: Circular RNAs

Frontiers in Cell and Developmental BiologyMarch 27, 2020
Anh M TranGeorge A Calin
2
Genome Biology

Renaissance minds in 21st century science

Genome BiologyMarch 15, 2020
Itai Yanai, Martin Lercher
61
Genome Biology

VALOR2: characterization of large-scale structural variants using linked-reads

Genome BiologyMarch 21, 2020
Fatih KaraoğlanoğluCan Alkan
22
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology

Identification of a functional human-unique 351-bp Alu insertion polymorphism associated with major depressive disorder in the 1p31.1 GWAS risk loci

Neuropsychopharmacology : Official Publication of the American College of NeuropsychopharmacologyMarch 21, 2020
Weipeng LiuXiao Xiao
2
Nucleic Acids Research

The genomic landscape of 8-oxodG reveals enrichment at specific inherently fragile promoters

Nucleic Acids ResearchMarch 22, 2020
Francesca GoriniStefano Amente
1
Nucleic Acids Research

Using GARDEN-NET and ChAseR to explore human haematopoietic 3D chromatin interaction networks

Nucleic Acids ResearchMarch 18, 2020
Miguel Madrid-MencíaVera Pancaldi
24
Nucleic Acids Research

Loop-closure kinetics reveal a stable, right-handed DNA intermediate in Cre recombination

Nucleic Acids ResearchMarch 18, 2020
Massa J ShouraStephen D Levene
5

See more papers from this feed

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

© 2020 Meta ULC. All rights reserved
/feed-previews/non-coding-variants-in-cancer-keystone/5b806ba5-678c-4b93-8ef9-ad913982356b